Cancer therapy: Tumours switch to resist
Menée à l'aide d'un modèle murin de mélanome, cette étude met en évidence un mécanisme de résistance à un traitement par transfert adoptif de cellules T
Tumour cells can respond to targeted immune-cell therapies by losing proteins that mark them as being cancerous. Subverting this resistance mechanism may lead to more durable cancer-treatment strategies.Tumour cells can respond to targeted immune-cell therapies by losing proteins that mark them as being cancerous. Subverting this resistance mechanism may lead to more durable cancer-treatment strategies.
Nature , commentaire, 2011